This extensive report delves into four years of research, providing in-depth analysis of antimicrobial usage trends amidst the COVID-19 pandemic and offering crucial insights for shaping future public health approaches.
This report shedding light on various aspects of antimicrobial stewardship (AMS) and antibiotic safety before and during the COVID-19 pandemic.
The antimicrobial research study (2020-2024) aimed to tackle antimicrobial resistance (AMR) through comprehensive research and impactful dissemination.
Research Phases:
1. Systematic Literature Review (2020-2021): A thorough literature review was conducted to establish a foundational understanding of antimicrobial resistance and stewardship.
2. Cross-Sectional Studies (2021-2023):
Ethical Approval (2021): Ethical clearance was obtained for the study.
Retrospective Patient Medical Records Review (2021-2022): Data was collected from historical patient records to identify trends in antimicrobial use.
Prospective Healthcare Professionals Survey (2021-2023): Surveys were conducted to capture healthcare professionals' perspectives and practices regarding antimicrobial stewardship.
3. Writing and Preparing Reports (2022-2024):
Writing follow-up reports, thesis, and preparing for viva examination.
Drafting and submitting publications, articles, and final reports.
Summary of Antimicrobial Research Study (2020-2024)
Impact and Dissemination:
1. Conference Abstract Submission (2023-2024): Findings were shared through abstracts submitted for oral and poster presentations.
2. Engagement via Media (2023-2024): Dissemination of results and stewardship strategies through blogs, posters, storytelling, videos, social media, and the WHO research community.
The study highlighted crucial shifts in antibiotic use during the COVID-19 pandemic and reinforced the need for effective antimicrobial stewardship strategies to combat AMR.
The key findings from this research project, include:
One crucial aspect explored in the report is the implementation of AMS strategies before and during the pandemic. The systematic review conducted in acute care settings reveals key findings regarding the effectiveness of AMS interventions and measures. It emphasises the importance of selecting appropriate AMS strategies to combat the increasing threat of antimicrobial resistance (AMR), particularly in crisis situations like the COVID-19 pandemic. Additionally, the systematic review highlights the need for further empirical research to evaluate the efficacy of different strategies in different contexts, ensuring preparedness for future health crises.
Another focal point of the report is the evaluation of antibiotic safety practices, particularly the adherence to the 'Five Rights of Antibiotic Safety,' in an NHS Foundation Trust. The study highlights significant shifts in antibiotic prescribing patterns during the pandemic, with concerning increases in inappropriate dosing and administration routes. These findings emphaised the critical role of robust AMS practices in ensuring the appropriate use of antibiotics, safeguarding patient safety, and combating AMR.
Furthermore, the report delves into the classification of antibiotics using the WHO AWaRe Classification, providing insights into antibiotic prescribing trends and shifts during the pandemic. The study reveals changes in antibiotic utilisation patterns, emphasising the urgency of implementing comprehensive AMS measures to address the evolving threat of AMR.
Lastly, the report discusses the impact of the COVID-19 pandemic on AMS implementation at an NHS Foundation Trust, in the duration of prescribed antibiotics, and the UKHSA stewardship toolkit, Start Smart Then Focus, and focused on how pharmacists can contribute to effective antimicrobial reviews. It highlights the importance of sustained stewardship efforts to ensure adherence to guidelines and combat resistance both during and after the pandemic era.
Antimicrobial Stewardship Action Plan or Actionable Recommendation
1. Implement Tailored AMS Strategies: Utilise findings to develop targeted interventions addressing shifts in prescribing patterns, focusing on reducing inappropriate dosing and administration routes.
2. Enhance AMS Education and Training: Develop comprehensive training programmes for healthcare professionals on antibiotic safety practices, emphasising adherence to the 'Five Rights of Antibiotic Safety.'
3. Strengthen Antibiotic Review Processes: Implement systematic antibiotic review protocols, leveraging tools like the UKHSA stewardship toolkit to optimise antibiotic use and combat antimicrobial resistance.
4. Foster Interdisciplinary Collaboration: Encourage collaboration between healthcare professionals, including pharmacists, to enhance antimicrobial reviews and ensure adherence to guidelines.
5. Promote AMS Awareness: Raise awareness among healthcare staff and patients about the importance of antimicrobial stewardship in safeguarding public health and combating AMR.
Download the report for actionable recommendations to shape effective antimicrobial stewardship practices and safeguard patient health.
The "Final Report: Real-World Insights on Antimicrobial Use Study During the Pandemic (2020 - 2024)" provides crucial findings shaping antimicrobial stewardship. Key insights include shifts in prescribing patterns, emphasizing robust AMS strategies to combat antimicrobial resistance and safeguard patient health. Download now for actionable recommendations.
In conclusion, the report emphsises the critical importance of AMS and antibiotic safety practices in mitigating the threat of AMR, particularly in the context of the COVID-19 pandemic. It calls for continued research, collaboration, and implementation of evidence-based strategies to safeguard public health and save lives worldwide.